Actos Cancer Direct

Actos is a brand-name prescription drug (generic name: ) manufactured by Takeda Pharmaceuticals . It belongs to a class of drugs called thiazolidinediones, designed to help adults with type 2 diabetes manage their blood sugar levels by improving insulin sensitivity. 2. The Connection to Bladder Cancer

In 2011, the FDA issued a safety communication warning about these risks. Around the same time, countries like France and Germany suspended or restricted the use of the drug. ACTOS CANCER

Research has suggested that long-term use of Actos may be associated with a higher risk of developing bladder cancer. Actos is a brand-name prescription drug (generic name: